Log in to Thinknum

Interested in Thinknum?

Request a demo
AK

Achaogen

- NASDAQ:AKAO
Last Updated 2019-05-24

LinkedIn Profile

Access Achaogen historical Linkedin company profile data on number of followers, employee headcount and more

Records

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Ticker Sector Ticker Industry
nasdaq:akao 57863 May 25th, 2019 12:00AM Achaogen 5.9K 142.00 Open Biotechnology May 25th, 2019 01:51PM May 25th, 2019 01:51PM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 May 24th, 2019 12:00AM Achaogen 5.9K 142.00 Open Biotechnology May 23rd, 2019 10:07PM May 23rd, 2019 10:07PM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 May 23rd, 2019 12:00AM Achaogen 5.9K 142.00 Open Biotechnology May 23rd, 2019 10:38AM May 23rd, 2019 10:38AM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 May 22nd, 2019 12:00AM Achaogen 5.9K 142.00 Open Biotechnology May 22nd, 2019 02:21PM May 22nd, 2019 02:21PM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 May 21st, 2019 12:00AM Achaogen 5.9K 142.00 Open Biotechnology May 21st, 2019 10:14AM May 21st, 2019 10:14AM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 May 20th, 2019 12:00AM Achaogen 5.9K 142.00 Open Biotechnology May 19th, 2019 10:06PM May 19th, 2019 10:06PM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 May 19th, 2019 12:00AM Achaogen 5.9K 142.00 Open Biotechnology May 19th, 2019 03:28PM May 19th, 2019 03:28PM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 May 18th, 2019 12:00AM Achaogen 5.9K 142.00 Open Biotechnology May 18th, 2019 10:29AM May 18th, 2019 10:29AM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 May 17th, 2019 12:00AM Achaogen 5.9K 142.00 Open Biotechnology May 17th, 2019 04:02PM May 17th, 2019 04:02PM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 May 16th, 2019 12:00AM Achaogen 5.8K 144.00 Open Biotechnology May 15th, 2019 10:06PM May 15th, 2019 10:06PM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.